Advisors Asset Management, Inc.
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1297376
Monument, CO
Position in ARQT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,515,389
+$651,417 QoQ
Shares Held
95,934
+21.3% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#102
of 270 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $39,929,265 across 31 Biotechnology names. ARQT ranks #4 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
25,909 | $12,869,777 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
17,228 | $5,445,598 | |
| 3 | INCY |
Incyte Corp
|
24,359 | $2,761,336 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
95,934 | $2,515,389 | |
| 5 | ASND |
Ascendis Pharma A/S
|
9,146 | $2,439,421 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
21,896 | $2,431,112 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,379 | $1,483,401 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
15,280 | $1,246,389 |
All Filings in ARQT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,515,389 | 95,934 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,863,972 | 79,116 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,224,405 | 76,598 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $890,323 | 47,232 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $621,015 | 44,295 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $440,844 | 28,187 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $311,182 | 22,339 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||